Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

PMV Pharmaceuticals

Request full access

A Doylestown, Penn-based developer of p53-targeted small molecule drugs for the treatment of cancer

West Windsor Township, United StatesFounded 2013Biotech & Life Sciences

About PMV Pharmaceuticals

PMV Pharmaceuticals, Inc. is a pioneering biotechnology company focused on developing innovative treatments for cancer. The company specializes in creating first-in-class p53 regulators, targeting the most commonly mutated protein in human cancers. By harnessing over three decades of p53 biology, PMV Pharma combines a unique biological understanding with a strong focus on pharmaceutical development.

PMV Pharma operates in the biotechnology and pharmaceutical market, primarily serving patients suffering from various forms of cancer. The company's business model revolves around the research, development, and commercialization of novel cancer therapies. Revenue is generated through the successful development and eventual sale or licensing of their proprietary treatments.

The company is led by a team of industry and academic thought leaders who are dedicated to discovering new treatments for human diseases. This leadership team brings together extensive experience in both scientific research and pharmaceutical development, ensuring a robust approach to tackling cancer.

PMV Pharma's core mission is to harness the power of p53 to treat cancer, offering hope and potential cures to millions of patients worldwide. The company is headquartered in Cranbury, NJ, and continues to make significant strides in the field of oncology.

Source: Dealroom company data

At a glance

Status
Listed
Listing
IPO 2020

PMV Pharmaceuticals in the West Windsor Township ecosystem

Live from Dealroom

The PMV Pharmaceuticals office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

11 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

Series B and later8 investors entered at this stage

Team profiled 7 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Patents

Estimated portfolio value
$22M

20 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

See PMV Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.